• 2022-04-24 6:0:00.0 Saving lives through long-acting injectable innovation
  • 2022-04-25 6:0:00.0 Delivering innovations to low- and middle-income countries
  • 2022-03-24 6:0:00.0 Living with TB - my experience
  • 2022-03-24 6:0:00.0 Reducing the burden of TB in the world’s most in need communities with long-acting injectables
  • 2022-03-24 6:0:00.0 Investing in TB prevention strategies with Long-Acting injectables
  • 2022-07-28 24:0:00.0 Developing a single-injection cure for hepatitis C virus for low- and middle-income countries
  • 2022-07-28 24:0:00.0 Community engagement – shaping the long-acting technologies pipeline
  • 2022-09-12 9:0:00.0 Taking control of the HIV epidemic – How long-acting injectables can help reach ambitious targets
  • 2022-12-01 24:0:00.0 Researchers from the Centre of Excellence for Long-acting Therapeutics featured prominently in leading scientific journal for clinical infectious diseases
  • 2022-12-21 9:0:00.0 Elliot Croft Wins the Roy Mapstone Prize for Developing Novel Long-Acting Microarray Patches at the 27th Ophthalmology and Vision Science Research Prize Meeting
  • 2023-01-13 11:0:00.0 Developing the Long-acting Pipeline: Data analysis, Modelling and accelerating development of Long-acting therapeutics
  • 2023-02-18 21:10:00.0 LAPaL, the Long-Acting Therapeutics Patents and Licences Database, is now available with enhanced features to track new drug development
  • 2023-08-07 7:47:37.0 Liverpool host LONGEVITY consortium